The use of ischemia modified albumin as a predictive and prognostic biomarker in patients with non–acetaminophen-induced acute liver failure. Ann Med Res [Internet]. 2022 Aug. 26 [cited 2025 Apr. 3];29(8):846-52. Available from: http://annalsmedres.org/index.php/aomr/article/view/4236